Does IPILIMUMAB Cause Hepatitis? 571 Reports in FDA Database

Q: Does IPILIMUMAB cause Hepatitis?

571 reports of Hepatitis have been filed with the FDA for IPILIMUMAB, representing 1.6% of all IPILIMUMAB adverse event reports.

Q: How dangerous is Hepatitis from IPILIMUMAB?

Of 571 reports, 88 (15.4%) resulted in death and 288 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 571 reports of Hepatitis have been filed in association with IPILIMUMAB (YERVOY). This represents 1.6% of all adverse event reports for IPILIMUMAB.

571

Reports of Hepatitis with IPILIMUMAB

1.6%

of all IPILIMUMAB reports

Deaths

288

Hospitalizations

How Dangerous Is Hepatitis From IPILIMUMAB?

Of the 571 reports, 88 (15.4%) resulted in death, 288 (50.4%) required hospitalization, and 62 (10.9%) were considered life-threatening.

Is Hepatitis Listed in the Official Label?

Yes, Hepatitis is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.

What Other Side Effects Does IPILIMUMAB Cause?

Death (3,710) Malignant neoplasm progression (3,296) Diarrhoea (2,557) Off label use (2,097) Colitis (1,988) Pyrexia (1,796) Rash (1,556) Fatigue (1,447) Intentional product use issue (1,329) Nausea (1,169)

What Other Drugs Cause Hepatitis?

METHOTREXATE (1,835) ACETAMINOPHEN (1,450) TOCILIZUMAB (1,184) HYDROXYCHLOROQUINE (1,133) ADALIMUMAB (1,096) RITUXIMAB (1,017) ETANERCEPT (1,013) LEFLUNOMIDE (997) PEMBROLIZUMAB (935) NIVOLUMAB (930)

Which IPILIMUMAB Alternatives Have Lower Hepatitis Risk?

IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE IPILIMUMAB vs IPRATROPIUM IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS IPILIMUMAB vs IPTACOPAN IPILIMUMAB vs IRBESARTAN

IPILIMUMAB Full Profile All Hepatitis Reports All Drugs Causing Hepatitis IPILIMUMAB Demographics